Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
IntelGenx Technologies (TSE:IGX)
TSX:IGX
IntelGenx Technologies (IGX) Stock Price & Analysis
9 Followers
IGX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.14 - C$0.30
Previous CloseC$0.22
Volume12.04K
Average Volume (3M)20.20K
Market Cap
C$39.09M
Enterprise ValueC$56.45M
Total Cash (Recent Filing)$2.28M
Total Debt (Recent Filing)$15.00M
Price to Earnings (P/E)-2.9
Beta1.79
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding174,658,096
10 Day Avg. Volume30,444
30 Day Avg. Volume20,197
Standard Deviation0.24
R-Squared0.32
Alpha-0.00713
Financial Highlights & Ratios
Price to Book (P/B)-2.37
Price to Sales (P/S)36.98
Price to Cash Flow (P/CF)-13.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue54.33
Enterprise Value/Gross Profit54.33
Enterprise Value/Ebitda-7.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IntelGenx Technologies News
PremiumCompany Announcements
IntelGenx Shareholders Approve All Resolutions
PremiumCompany Announcements
IntelGenx Trials Novel Parkinson’s Treatment
PremiumCompany Announcements
IntelGenx Faces FDA Hurdle for Pain Management Drug
Options Prices
Currently, No data available
---
Ownership Overview
43.32%
Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
56.68% Public Companies and
Individual Investors
IGX FAQ
What was IntelGenx Technologies’s price range in the past 12 months?
IntelGenx Technologies lowest stock price was C$0.14 and its highest was C$0.30 in the past 12 months.
What is IntelGenx Technologies’s market cap?
Currently, no data Available
When is IntelGenx Technologies’s upcoming earnings report date?
IntelGenx Technologies’s upcoming earnings report date is Aug 08, 2024 which is in 85 days.
How were IntelGenx Technologies’s earnings last quarter?
Currently, no data Available
Is IntelGenx Technologies overvalued?
According to Wall Street analysts IntelGenx Technologies’s price is currently Overvalued.
Does IntelGenx Technologies pay dividends?
IntelGenx Technologies does not currently pay dividends.
What is IntelGenx Technologies’s EPS estimate?
IntelGenx Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IntelGenx Technologies have?
IntelGenx Technologies has 174,658,100 shares outstanding.
What happened to IntelGenx Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IntelGenx Technologies?
Currently, no hedge funds are holding shares in TSE:IGX
---
IntelGenx Technologies Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.49%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-9.88%
Trailing 12-Months
Company Description
IntelGenx Technologies
IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The company also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research & development, clinical monitoring, regulatory support, tech transfer & manufacturing scale-up and commercial manufacturing. IntelGenx Technologies was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
---
IGX Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
IntelGenx Technologies
―
Supernus Pharmaceuticals
―
Eton Pharmaceuticals
―
Innoviva
―
---